News
Barclays Maintains Equal-Weight on Biogen, Lowers Price Target to $200
25 Apr 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Biogen, Lowers Price Target to $300
25 Apr 24
News, Price Target, Analyst Ratings
Needham Reiterates Buy on Biogen, Maintains $294 Price Target
25 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
24 Apr 24
Biotech, Large Cap, News, Health Care, Movers, Trading Ideas, General
Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings
24 Apr 24
Biotech, Earnings, Large Cap, News, Guidance, Health Care, Top Stories, Movers, Trading Ideas, General
Needham Reiterates Buy on Biogen, Maintains $294 Price Target
24 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
21 Apr 24
Analyst Color, Equities, News, Top Stories, Tech, Trading Ideas
Wedbush Maintains Neutral on Biogen, Lowers Price Target to $213
17 Apr 24
News, Price Target, Analyst Ratings
B of A Securities Maintains Neutral on Biogen, Lowers Price Target to $260
12 Apr 24
News, Price Target, Analyst Ratings
Where Biogen Stands With Analysts
11 Apr 24
Analyst Ratings
JP Morgan Maintains Neutral on Biogen, Lowers Price Target to $240
11 Apr 24
News, Price Target, Analyst Ratings
10 Health Care Stocks With Whale Alerts In Today's Session
9 Apr 24
Options
Barclays Maintains Equal-Weight on Biogen, Lowers Price Target to $215
4 Apr 24
News, Price Target, Analyst Ratings
Looking Into Biogen's Recent Short Interest
3 Apr 24
Short Sellers, Short Ideas, Trading Ideas
Forecasting The Future: 18 Analyst Projections For Biogen
25 Mar 24
Analyst Ratings
Truist Securities Reiterates Buy on Biogen, Maintains $340 Price Target
25 Mar 24
News, Price Target, Reiteration, Analyst Ratings
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
22 Mar 24
Biotech, Large Cap, News, Health Care, Movers, General
10 Health Care Stocks With Whale Alerts In Today's Session
20 Mar 24
Options
10 Health Care Stocks With Whale Alerts In Today's Session
19 Mar 24
Options
AbCellera To Collaborate With Biogen To Discover Therapeutic Antibodies For Neurological Conditions
11 Mar 24
Biotech, News, General
Press releases
Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
31 Mar 24
Press Releases
Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
21 Mar 24
Press Releases
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
20 Mar 24
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
20 Mar 24
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
20 Mar 24
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
20 Mar 24
News, Press Releases
Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
14 Mar 24
Press Releases
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIB
12 Mar 24
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIB
12 Mar 24
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIB
12 Mar 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIB
11 Mar 24
Press Releases
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
11 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIB
7 Mar 24
News, Legal, Press Releases
New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy
6 Mar 24
Press Releases, General
Biogen Highlights New Data at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD™) 2024 Annual Meeting
4 Mar 24
News, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIB
3 Mar 24
Press Releases
BIOGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Biogen Inc. on Behalf of Biogen Stockholders and Encourages Investors to Contact the Firm
24 Feb 24
News, Legal, Press Releases
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Biogen Inc. (BIIB) on Behalf of Investors
23 Feb 24
Press Releases
Biogen's QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
23 Feb 24
Press Releases, General
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Biogen Inc. (BIIB) on Behalf of Investors
22 Feb 24
Press Releases